Study | Country | Jadad score | GnRH-a group | Control group | Sample size | Time of Therapy | Follow-up | Outcomea | conception way |
---|---|---|---|---|---|---|---|---|---|
Saeed Alborzi 2010 [37] | Iran | 5 | Triptorelin 3.75Â mg | Without GnRH-a/ Letrozole | 40/57 /47 | 2Â M | 12Â M | afg | unclear |
Ibrahim Alkatout 2012 [46] | Germany | 5 | Leuprorelin 3.75Â mg | Without GnRH-a | 148/137 | 3Â M | 2Y | abcd | unclear |
Piyush Bansal 2018 [47] | India | 7 | Leuprodex 3.75 mg | Without GnRH-a | 41/42 | 1 M | 2 Y + 6 M | ab | SO + IUI |
M.Busacca 2001 [38] | Italy | 5 | Leuprolide 3.75Â mg | Without GnRH-a | 44/45 | 3Â M | 6-36Â M | ah | unclear |
Marcello Ceccaroni 2021 [41] | Italy | 3 | Triptorelin/ Leuprorelin 3.75 mg | Dienogest | 81/65 | 6 M | 30 ± 6 M | abh | ART/spontaneously |
W. Decleer 2016 [54] | Belgium | 6 | GnRH-a | Without GnRH-a | 61/58 | 3Â M | unclear | a | ART |
Haiyan Guo 2022 [51] | China | 5 | GnRH-a | Medroxyprogesterone | 150/150 | 1Â M | unclear | abcde | ART |
Giuseppe Loverro 2006 [43] | Italy | 3 | Triptorelin 3.75Â mg | Without GnRH-a | 29/25 | 3Â M | 5Y | ag | spontaneously |
Recai Pabuccu 2007 [52] | Turkey | 5 | GnRH-a | GnRH-ant | 48/50 | 1Â M | unclear | ac | ART |
Dagmar Rickes 2002 [49] | Germany | 5 | Goserelin 3.6Â mg | Without GnRH-a | 55/55 | 6Â M | 4 w | a | ART |
Elisabet Rodr´ıguez-Tarrega 2020 [42] | Italy | 7 | Triptorelin 3.75 mg | placebo | 91/92 | 3 M | unclear | abcde | ART |
Eric S. Surrey 2002 [48] | California | 5 | Leuprolide 3.75Â mg | Without GnRH-a | 25/26 | 3Â M | unclear | af | ART |
Paolo Vercellini 1999 [50] | Italy | 5 | Goserelin 3.6Â mg | Without GnRH-a | 107/103 | 6Â M | 2Y | ag | unclear |
Huiling Xue 2018 [44] | China | 4 | Triptorelin 3.75Â mg | Gestrinone/ Mifepristone | 50/50 /50 | 3Â M | 2Y | abcdgh | unclear |
Xin-hua Yang 2014 [36] | China | 2 | Goserelin (Zoladex) 3.6Â mg | Without GnRH-a | 63/62 | 3Â M | 18Â M | afg | spontaneously |
Yu Yang 2019 [45] | China | 2 | Triptorelin 3.75Â mg | Without GnRH-a | 65/65 | 6Â M | 2Y | agh | unclear |
ZHAO Rui-hua 2012 [53] | China | 2 | GnRH-a 3.75 mg | CM | 102/106 | 6 M (stage I-II:3 M) | 20.66 ± 6.75/20.83 ± 6.65 M | afgh | unclear |